Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GON and SON Blockade in Acute Migraine
NCT04491474Phase 4Completed
- Sponsor
- Kartal Dr. Lütfi Kırdar City Hospital
- Start
- Aug 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine in migraine (4 arms), sponsored by Kartal Dr. Lütfi Kırdar City Hospital. Primary endpoint: Visual Analog Scale Pain Measurements at 120 months. Started Aug 2020; status: completed.
02
Drugs
lidocaine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04491474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04491474.